Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-08-11

Clinical Trial Update: Longterm Outcome of the Delta III Inverse Prosthesis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the Delta III inverse prosthesis for Rotator Cuff Tear Arthropathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Delta III Inverse Prosthesis

Snippet

Sponsor: Schulthess Klinik | Conditions: Rotator Cuff Tear Arthropathy | Phase 4 | Status: WITHDRAWN